Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancerEdith A. Perez, Paul Anthony Ellis|BMC Cancer|2019Cited by 67